May 21, 2024
$68.3 million of Net Revenue +21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk Makeup Adjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand
May 1, 2024
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced its participation in the CreatorIQ Connect Europe conference, which will be held in London on Thursday, May 2, 2024.
April 30, 2024
2023 Net Revenue of $218.1 million Group Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022 Group Combined Adjusted EBITDA of $24.4 million, up from ($8.8) million in 2022 WHITE PLAINS, N.Y., April 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the
March 25, 2024
WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained
March 20, 2024
—  H1’23 Total Net Revenue of $109.3 million —  H1’23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1’22 —  Introduces guidance WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and
February 26, 2024
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that by decision dated February 22, 2024, a Nasdaq Hearings Panel (the “Panel”) granted Waldencast’s request for continued listing on The
Displaying 1 - 10 of 13
Print Page
Investor FAQs
RSS Feeds
Email Alerts
Contact IR